Ignite Creation Date:
2024-05-06 @ 6:24 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05640128
Status:
RECRUITING
Last Update Posted:
2022-12-07
First Post:
2022-11-28
Brief Title:
Determination of Threshold Values of Aldosterone in HPLC-MSMS of Renin and of the Aldosterone Renin Ratio for the Diagnosis of Primary Hyperaldosteronism
Sponsor:
University Hospital Caen
Organization:
University Hospital Caen
Study Overview
Official Title:
Determination of Threshold Values of Aldosterone in HPLC-MSMS of Renin and of the Aldosterone Renin Ratio for the Diagnosis of Primary Hyperaldosteronism
Status:
RECRUITING
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DAPS
Brief Summary:
collaborative work within 2 hospitals at the CHU of Caen at the CHRU of Lille concerning the evaluation of the biological markers of primary hyperaldosteronism PAH with the dosage of aldosterone in LC -MSMS which is performed in both centers with two different techniques The main objective is to define the range of Aldosterone concentrations in LC MSMS of renin in an automated method in populations of healthy volunteers essential hypertensives and hypertensives with primary hyperaldosteronism in order to establish a threshold for the screening of PAH by the RAR and for the confirmation of PAH by a dynamic test with an Aldosterone threshold post salt load test
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None